RxDoctor Payments Data

William Sovic

Dallas, TXNPI 1225590813

Payments from drug & device makers

What this record shows

This record is dominated by grants: $45,000 of the $59,871 with a category attached, or 75.2%. 12 manufacturers reported payments, led by Abbott at 49.2% of the total. 2025 is the largest year on record at $56,560, more than ten times the $231 reported in 2022.

$59,871in general payments, 2019–2025

Across 148 payments — averaging $404.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$29K
  • Medtronic$22K
  • Boston Scientific$5K
  • Biotronik Inc.$2K
  • Edwards Lifesciences$318
  • Philips North America LLC$309
  • plus $526 from 6 others

What the payments were for

  • Grants$45,00075%
  • Travel & lodging$7,96713%
  • Food & beverage$6,50711%
  • Education$3971%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan36$29,344
JardianceEmpagliflozin20$25,832
ClopidogrelClopidogrel Bisulfate20$145
Carvedilol16$57
Atorvastatin Calcium11$43

Paid to pharmacies, not to this prescriber.

Where these figures come from

Is this you, or does something look wrong? →